BioNTech expects to be $18.6B richer after this year as Covid boosters churn out more data. But it won’t change much

Pfizer unveiled the riches that its Covid-19 vaccine is showering on itself and partners at BioNTech when it pegged 2021 sales at $33.5 billion. If the German biotech — which is in charge of designing the current vaccine and future mRNA boosters — is right, it could become a major...

Click to view original post